Telmisartan (Glenmark Pharmaceuticals Inc., USA)
Welcome to the PulseAid listing for the Telmisartan drug offered from Glenmark Pharmaceuticals Inc., USA. This Angiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Glenmark Pharmaceuticals Inc., USA |
NON-PROPRIETARY NAME: | Telmisartan |
SUBSTANCE NAME: | TELMISARTAN |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Angiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2014-07-07 |
END MARKETING DATE: | 0000-00-00 |
Telmisartan HUMAN PRESCRIPTION DRUG Details:
Item Description | Telmisartan from Glenmark Pharmaceuticals Inc., USA |
LABELER NAME: | Glenmark Pharmaceuticals Inc., USA |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 20(mg/1) |
START MARKETING DATE: | 2014-07-07 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 68462-199_4bd6558d-fd84-4eec-ad3d-249c8baf65c6 |
PRODUCT NDC: | 68462-199 |
APPLICATION NUMBER: | ANDA090032 |
Other TELMISARTAN Pharmaceutical Manufacturers / Labelers: